3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Terminated
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Small Cell Lung Carcinoma
2
Glioblastoma
2
Pancreatic Neoplasms
1
Pancreatic Cancer Metastatic
1
Neoplasms
1
Gliosarcoma
1
Interventions
Cisplatin
21
Etoposide
20
Carboplatin
20
Topotecan
13
pembrolizumab
12
durvalumab
11
Paclitaxel
10
Irinotecan
9
Nivolumab
7
Gemcitabine
7
tremelimumab
6
atezolizumab
6
Radiotherapy
6
Docetaxel
6
Pemetrexed
5
Ipilimumab
5
Cyclophosphamide
5
rovalpituzumab tesirine
4
budigalimab
4
Specimen Handling
4
Injections
4
Doxorubicin
4
Bortezomib
4
130-nm albumin-bound paclitaxel
4
venetoclax
3
talazoparib
3
olaparib
3
fludarabine
3
etoposide phosphate
3
Platinum
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Small Cell Lung Carcinoma
×
Chloroquine
×
Clear all
NCT00969306
2019-02-15
Chloroquine IV
Maastricht Radiation Oncology
Phase 1
Terminated
5 enrolled
NCT01575782
2017-07-18
Chloroquine
Maastricht Radiation Oncology
Phase 1
Terminated
5 enrolled